BIO-TECHNE Corp
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 98 trades on this page.
Director
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Director
Common Stock
Director
Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Director
Common Stock
Director
Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SVP - General Counsel
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
SVP - General Counsel
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
CFO
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
CFO
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
PRESIDENT, PROTEIN SCIENCES
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
PRESIDENT, PROTEIN SCIENCES
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President - Diag & Spatial Bi
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President - Diag & Spatial Bi
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chief Executive Officer
Common Stock
Chief Executive Officer
Performance Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Executive Officer
Performance Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chief Executive Officer
Performance Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chief Executive Officer
Performance Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Executive Officer
Performance Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chief Executive Officer
Performance Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chief Executive Officer
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Executive Officer
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CFO
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
CFO
Common Stock
CFO
Performance Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CFO
Performance Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
CFO
Performance Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
CFO
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CFO
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
PRESIDENT, PROTEIN SCIENCES
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
PRESIDENT, PROTEIN SCIENCES
Common Stock
PRESIDENT, PROTEIN SCIENCES
Performance Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
PRESIDENT, PROTEIN SCIENCES
Performance Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
PRESIDENT, PROTEIN SCIENCES
Performance Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
PRESIDENT, PROTEIN SCIENCES
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
PRESIDENT, PROTEIN SCIENCES
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SVP - General Counsel
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
SVP - General Counsel
Common Stock
SVP - General Counsel
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SVP - General Counsel
Performance Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
SVP - General Counsel
Performance Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SVP - General Counsel
Performance Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
SVP - General Counsel
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SVP - General Counsel
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
President - Diag & Spatial Bi
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
President - Diag & Spatial Bi
Common Stock
President - Diag & Spatial Bi
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
President - Diag & Spatial Bi
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
President - Diag & Spatial Bi
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Director
Common Stock
Director
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CFO
Common Stock
CFO
Common Stock
CFO
Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SVP - General Counsel
Common Stock
SVP - General Counsel
Common Stock
SVP - General Counsel
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
President - Diag & Spatial Bi
Common Stock
President - Diag & Spatial Bi
Common Stock
President - Diag & Spatial Bi
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
Director
Common Stock
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CFO
Common Stock
CFO
Common Stock
CFO
Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SVP - General Counsel
Common Stock
SVP - General Counsel
Common Stock
SVP - General Counsel
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
President - Diag & Spatial Bi
Common Stock
President - Diag & Spatial Bi
Common Stock
President - Diag & Spatial Bi
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Executive Officer
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chief Executive Officer
Common Stock
Chief Executive Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CFO
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
CFO
Common Stock
CFO
Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Executive Officer
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chief Executive Officer
Common Stock
Chief Executive Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SVP - General Counsel
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
SVP - General Counsel
Common Stock
SVP - General Counsel
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockOption exercise or conversion | 15,940$0 reported · see filing | Not established | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockExercise-price or tax withholding | 5,562$72.51 / share | $403.3K | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Stock Options (Right to Buy)Option exercise or conversion | Derivative units15,940$25.30 exercise / conversion price | Not a separate purchase | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion | 15,940$0 reported · see filing | Not established | Sep 22Filed Sep 24 · 2d later | SEC filing |
| Director | Common StockExercise-price or tax withholding | 5,559$72.55 / share | $403.31K | Sep 22Filed Sep 24 · 2d later | SEC filing |
| Director | Stock Options (Right to Buy)Option exercise or conversion | Derivative units15,940$25.30 exercise / conversion price | Not a separate purchase | Sep 22Filed Sep 24 · 2d later | SEC filing |
| SVP - General Counsel | Restricted Stock UnitsGrant or award | Derivative units11,344Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| SVP - General Counsel | Restricted Stock UnitsGrant or award | Derivative units18,432Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| Chief Executive Officer | Restricted Stock UnitsGrant or award | Derivative units57,590Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| Chief Executive Officer | Restricted Stock UnitsGrant or award | Derivative units93,582Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| CFO | Restricted Stock UnitsGrant or award | Derivative units22,438Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| CFO | Restricted Stock UnitsGrant or award | Derivative units36,459Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| Director | Restricted Stock UnitsGrant or award | Derivative units1,381Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| PRESIDENT, PROTEIN SCIENCES | Restricted Stock UnitsGrant or award | Derivative units14,762Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| PRESIDENT, PROTEIN SCIENCES | Restricted Stock UnitsGrant or award | Derivative units23,985Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| President - Diag & Spatial Bi | Restricted Stock UnitsGrant or award | Derivative units8,702Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| President - Diag & Spatial Bi | Restricted Stock UnitsGrant or award | Derivative units14,140Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| Chief Executive Officer | Common StockOption exercise or conversion | 21,470$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Chief Executive Officer | Common StockExercise-price or tax withholding | 10,821$72.40 / share | $783.44K | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Chief Executive Officer | Performance Restricted Stock UnitsOption exercise or conversion | Derivative units554Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Chief Executive Officer | Performance Restricted Stock UnitsDisposition to issuer | Derivative units8,319$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Chief Executive Officer | Performance Stock Options (Right to Buy)Disposition to issuer | Derivative units22,389$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Chief Executive Officer | Performance Restricted Stock UnitsOption exercise or conversion | Derivative units588Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Chief Executive Officer | Performance Restricted Stock UnitsDisposition to issuer | Derivative units8,835$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Chief Executive Officer | Performance Stock Options (Right to Buy)Disposition to issuer | Derivative units24,324$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Chief Executive Officer | Restricted Stock UnitsOption exercise or conversion | Derivative units8,543Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Chief Executive Officer | Restricted Stock UnitsOption exercise or conversion | Derivative units11,785Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| CFO | Common StockOption exercise or conversion | 9,779$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| CFO | Common StockExercise-price or tax withholding | 4,310$72.40 / share | $312.04K | Aug 15Filed Aug 18 · 3d later | SEC filing |
| CFO | Performance Restricted Stock UnitsOption exercise or conversion | Derivative units866Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| CFO | Performance Restricted Stock UnitsDisposition to issuer | Derivative units12,999$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| CFO | Performance Stock Options (Right to Buy)Disposition to issuer | Derivative units34,982$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| CFO | Restricted Stock UnitsOption exercise or conversion | Derivative units4,010Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| CFO | Restricted Stock UnitsOption exercise or conversion | Derivative units4,903Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| PRESIDENT, PROTEIN SCIENCES | Common StockOption exercise or conversion | 6,416$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| PRESIDENT, PROTEIN SCIENCES | Common StockExercise-price or tax withholding | 1,976$72.40 / share | $143.06K | Aug 15Filed Aug 18 · 3d later | SEC filing |
| PRESIDENT, PROTEIN SCIENCES | Performance Restricted Stock UnitsOption exercise or conversion | Derivative units567Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| PRESIDENT, PROTEIN SCIENCES | Performance Restricted Stock UnitsDisposition to issuer | Derivative units8,507$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| PRESIDENT, PROTEIN SCIENCES | Performance Stock Options (Right to Buy)Disposition to issuer | Derivative units22,898$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| PRESIDENT, PROTEIN SCIENCES | Restricted Stock UnitsOption exercise or conversion | Derivative units2,623Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| PRESIDENT, PROTEIN SCIENCES | Restricted Stock UnitsOption exercise or conversion | Derivative units3,226Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| SVP - General Counsel | Common StockOption exercise or conversion | 4,350$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| SVP - General Counsel | Common StockExercise-price or tax withholding | 1,343$72.40 / share | $97.23K | Aug 15Filed Aug 18 · 3d later | SEC filing |
| SVP - General Counsel | Restricted Stock UnitsOption exercise or conversion | Derivative units49Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| SVP - General Counsel | Performance Stock Option (Right to Buy)Disposition to issuer | Derivative units12,117$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| SVP - General Counsel | Performance Restricted Stock UnitsOption exercise or conversion | Derivative units300Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| SVP - General Counsel | Performance Restricted Stock UnitsDisposition to issuer | Derivative units4,502$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| SVP - General Counsel | Restricted Stock UnitsOption exercise or conversion | Derivative units1,669Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| SVP - General Counsel | Restricted Stock UnitsOption exercise or conversion | Derivative units2,332Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| President - Diag & Spatial Bi | Common StockOption exercise or conversion | 5,423$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| President - Diag & Spatial Bi | Common StockExercise-price or tax withholding | 1,947$72.40 / share | $140.96K | Aug 15Filed Aug 18 · 3d later | SEC filing |
| President - Diag & Spatial Bi | Restricted Stock UnitsOption exercise or conversion | Derivative units1,379Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| President - Diag & Spatial Bi | Restricted Stock UnitsOption exercise or conversion | Derivative units1,868Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| President - Diag & Spatial Bi | Restricted Stock UnitsOption exercise or conversion | Derivative units2,176Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Director | Common StockOption exercise or conversion | 589$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Director | Common StockExercise-price or tax withholding | 213$72.40 / share | $15.42K | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Director | Restricted Stock UnitsOption exercise or conversion | Derivative units118Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Director | Restricted Stock UnitsOption exercise or conversion | Derivative units160Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Director | Restricted Stock UnitsOption exercise or conversion | Derivative units311Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
| CFO | Common StockOption exercise or conversion | 62,068$47.60 / share | $2.95M | Jul 29Filed Jul 31 · 2d later | SEC filing |
| CFO | Common StockExercise-price or tax withholding | 51,024$72.03 / share | $3.68M | Jul 29Filed Jul 31 · 2d later | SEC filing |
| CFO | Stock Options (Right to Buy)Option exercise or conversion | Derivative units62,068$47.60 exercise / conversion price | Not a separate purchase | Jul 29Filed Jul 31 · 2d later | SEC filing |
| Chief Executive Officer | Common StockOption exercise or conversion | 35,000$47.60 / share | $1.67M | Jul 28Filed Jul 30 · 2d later | SEC filing |
| Chief Executive Officer | Common StockExercise-price or tax withholding | 28,686$72.07 / share | $2.07M | Jul 28Filed Jul 30 · 2d later | SEC filing |
| Chief Executive Officer | Stock Option (Right to Buy)Option exercise or conversion | Derivative units35,000$47.60 exercise / conversion price | Not a separate purchase | Jul 28Filed Jul 30 · 2d later | SEC filing |
| SVP - General Counsel | Common StockOption exercise or conversion | 448$47.60 / share | $21.32K | Jul 23Filed Jul 27 · 4d later | SEC filing |
| SVP - General Counsel | Common StockExercise-price or tax withholding | 344$71.77 / share | $24.69K | Jul 23Filed Jul 27 · 4d later | SEC filing |
| SVP - General Counsel | Stock Option (Right to Buy)Option exercise or conversion | Derivative units448$47.60 exercise / conversion price | Not a separate purchase | Jul 23Filed Jul 27 · 4d later | SEC filing |
| President - Diag & Spatial Bi | Common StockOption exercise or conversion | 600Price not reported | Unavailable | Jun 2Filed Jun 4 · 2d later | SEC filing |
| President - Diag & Spatial Bi | Common StockExercise-price or tax withholding | 216$49.77 / share | $10.75K | Jun 2Filed Jun 4 · 2d later | SEC filing |
| President - Diag & Spatial Bi | Restricted Stock UnitsOption exercise or conversion | Derivative units600Exercise / conversion price not reported | Not a separate purchase | Jun 2Filed Jun 4 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion | 6,636$47.60 / share | $315.87K | May 8Filed May 12 · 4d later | SEC filing |
| Director | Common StockSale | 6,636$48.28 / share | $320.39K | May 8Filed May 12 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Option exercise or conversion | Derivative units6,636$47.60 exercise / conversion price | Not a separate purchase | May 8Filed May 12 · 4d later | SEC filing |
| CFO | Common StockOption exercise or conversion | 62,000$47.60 / share | $2.95M | May 5Filed May 7 · 2d later | SEC filing |
| CFO | Common StockExercise-price or tax withholding | 56,955$56.68 / share | $3.23M | May 5Filed May 7 · 2d later | SEC filing |
| CFO | Stock Options (Right to Buy)Option exercise or conversion | Derivative units62,000$47.60 exercise / conversion price | Not a separate purchase | May 5Filed May 7 · 2d later | SEC filing |
| SVP - General Counsel | Common StockOption exercise or conversion | 8,400$47.60 / share | $399.84K | May 5Filed May 7 · 2d later | SEC filing |
| SVP - General Counsel | Common StockExercise-price or tax withholding | 7,055$56.68 / share | $399.88K | May 5Filed May 7 · 2d later | SEC filing |
| SVP - General Counsel | Stock Option (Right to Buy)Option exercise or conversion | Derivative units8,400$47.60 exercise / conversion price | Not a separate purchase | May 5Filed May 7 · 2d later | SEC filing |
| Chief Executive Officer | Common StockOption exercise or conversion | 26,692$47.60 / share | $1.27M | May 5Filed May 7 · 2d later | SEC filing |
| Chief Executive Officer | Common StockExercise-price or tax withholding | 23,951$56.68 / share | $1.36M | May 5Filed May 7 · 2d later | SEC filing |
| Chief Executive Officer | Stock Option (Right to Buy)Option exercise or conversion | Derivative units26,692$47.60 exercise / conversion price | Not a separate purchase | May 5Filed May 7 · 2d later | SEC filing |
| President - Diag & Spatial Bi | Common StockOption exercise or conversion | 794Price not reported | Unavailable | May 1Filed May 5 · 4d later | SEC filing |
| President - Diag & Spatial Bi | Common StockExercise-price or tax withholding | 311$55.02 / share | $17.11K | May 1Filed May 5 · 4d later | SEC filing |
| President - Diag & Spatial Bi | Restricted Stock UnitsOption exercise or conversion | Derivative units794Exercise / conversion price not reported | Not a separate purchase | May 1Filed May 5 · 4d later | SEC filing |
| Chief Executive Officer | Common StockOption exercise or conversion | 11,344$0 reported · see filing | Not established | Apr 22Filed Apr 24 · 2d later | SEC filing |
| Chief Executive Officer | Common StockExercise-price or tax withholding | 1,363$58.58 / share | $79.84K | Apr 22Filed Apr 24 · 2d later | SEC filing |
| Chief Executive Officer | Stock Option (Right to Buy)Option exercise or conversion | Derivative units11,344$47.60 exercise / conversion price | Not a separate purchase | Apr 22Filed Apr 24 · 2d later | SEC filing |
| CFO | Common StockOption exercise or conversion | 62,000$0 reported · see filing | Not established | Apr 22Filed Apr 24 · 2d later | SEC filing |
| CFO | Common StockExercise-price or tax withholding | 56,097$58.58 / share | $3.29M | Apr 22Filed Apr 24 · 2d later | SEC filing |
| CFO | Stock Options (Right to Buy)Option exercise or conversion | Derivative units62,000$47.60 exercise / conversion price | Not a separate purchase | Apr 22Filed Apr 24 · 2d later | SEC filing |
| Chief Executive Officer | Common StockOption exercise or conversion | 36,500$0 reported · see filing | Not established | Apr 14Filed Apr 16 · 2d later | SEC filing |
| Chief Executive Officer | Common StockExercise-price or tax withholding | 32,088$58.66 / share | $1.88M | Apr 14Filed Apr 16 · 2d later | SEC filing |
| Chief Executive Officer | Stock Option (Right to Buy)Option exercise or conversion | Derivative units36,500$47.60 exercise / conversion price | Not a separate purchase | Apr 14Filed Apr 16 · 2d later | SEC filing |
| SVP - General Counsel | Common StockOption exercise or conversion | 2,259$0 reported · see filing | Not established | Apr 3Filed Apr 7 · 4d later | SEC filing |
| SVP - General Counsel | Common StockExercise-price or tax withholding | 740$53.13 / share | $39.32K | Apr 3Filed Apr 7 · 4d later | SEC filing |
| SVP - General Counsel | Restricted Stock UnitsOption exercise or conversion | Derivative units2,259Exercise / conversion price not reported | Not a separate purchase | Apr 3Filed Apr 7 · 4d later | SEC filing |
Bio-Techne Corp - Common Stock (TECH) · Stock
The filing reports a sale for a dependent.
April McClain DelaneyReporting House memberBio-Techne Corp - Common Stock (TECH) · Stock
The filing reports a partial sale for a dependent.
April McClain DelaneyReporting House memberBio-Techne Corp - Common Stock (TECH) · Stock
The filing reports a partial sale for a dependent.
April McClain DelaneyReporting House memberBio-Techne Corp - Common Stock (TECH) · Stock
The filing reports a partial sale for a dependent.
April McClain DelaneyReporting House memberBio-Techne Corp - Common Stock (TECH) · Stock
The filing reports a purchase for a dependent.
April McClain DelaneyReporting House memberBio-Techne Corp - Common Stock (TECH) · Stock
The filing reports a purchase for a dependent.
April McClain DelaneyReporting House memberBio-Techne Corp - Common Stock (TECH) · Stock
The filing reports a purchase for a dependent.
April McClain DelaneyReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
